Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07556159 · ClinicalTrials.gov registry record
A Study Evaluating Disease Characteristics and Outcomes in Participants With Asthma in Routine Clinical Practice
A clinical trial, sponsored by Sanofi.
- Recruiting
- Registry status
- 2,500
- Enrollment target
NCT07556159: Recruiting study, sponsored by Sanofi.
NCT07556159 is a clinical trial that is actively recruiting participants, run by Sanofi. The registered enrollment target is 2,500 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07556159 is actively recruiting participants, sponsored by Sanofi.
- RECRUITING
- Registry status
- 2,500 participants
- Enrollment target
Study Summary
The main aim of the study to describe the characteristics of participants with asthma across the spectrum of disease severity, including sociodemographic and clinical characteristics, treatment and disease burden, biomarkers, and both disease-specific and generic health-related quality of life. The study consists of two parts: a cross-sectional study, and a prospective follow-up evaluate changes in disease trajectories in participants with asthma.
Primary Outcome
Descriptive Statistical Analyses may include sociodemographic and clinical characteristics, comorbidities, exacerbation history, medication burden, biomarkers and lung function.
Interventions
- OTHER Procedure: Investigational Procedures
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,500 participants |
| Start Date | 2026-04-01 |
| Est. Completion | 2029-04-04 |
What NCT07556159 shows while recruiting
NCT07556159 is an observational study that tracks outcomes without assigning an intervention. Its 2,500 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Procedure: Investigational Procedures is the first listed.
NCT07556159 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07556159 about?
NCT07556159 is a clinical study titled "A Study Evaluating Disease Characteristics and Outcomes in Participants With Asthma in Routine Clinical Practice". The main aim of the study to describe the characteristics of participants with asthma across the spectrum of disease severity, including sociodemographic and clinical characteristics, treatment and disease burden, biomarkers, and both disease-specific and generic health-related quality of life. The...
What is the current status of trial NCT07556159?
This trial is currently recruiting. The enrollment target is 2,500 participants. The study started on 2026-04-01. Estimated completion is 2029-04-04.
What interventions are being tested in trial NCT07556159?
The interventions under investigation include: Procedure: Investigational Procedures (OTHER).
Who is sponsoring clinical trial NCT07556159?
This trial is sponsored by Sanofi, which has 713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001160 · 2,500 participants
Studies on Tumors of the Thyroid
- NCT01904188 · 2,500 participants
Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?
- NCT02257229 · 2,500 participants
Prospective Evaluation of Treatment for Clubfoot
- NCT02530658 · 2,500 participants
Next Generation Sequencing of Normal Tissues Prospectively in Pediatric Oncology Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI